The production, sale and export of medicinal marijuana are strictly regulated. Despite this, patients know less about the contents and origins of their medication than recreational users. Why is this and what could be improved?
Although the production, sales and export of medical marijuana from Canada and the Netherlands are fully and strictly regulated, patients in Canada, Germany, the Czech Republic and the Netherlands generally only know the THC and CBD levels of their medication. While these are stated precisely, down to one tenth of one percent, for many varieties neither their ancestry nor their cannabinoid or terpene profiles are known.
Recreational users better off
In some US states, and the Netherlands and Canada, recreational users may often be better off because source locations (coffee shops and dispensaries) name their products logically and voluntarily submit them for testing for the most common terpenes and cannabinoids.
Among large producers of medicinal marijuana, the creation of any such full spectrum…